Bottom line
What is POMGX's expense ratio?
POMGX's expense ratio is 0.8%, or about $80 a year on every $10,000 invested. That is cheaper than 51% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 4%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Dec 23, 2025
POMGX fee table
| Net expense ratio | 0.8% |
|---|---|
| Gross expense ratio | 2.33% |
| Management fee | 0.36% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 1.28% |
| Acquired fund fees | 0.44% |
| Fee waiver / reimbursement | -1.53% |
| Max front-end sales load | 4% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What POMGX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| POMGX | $478 | $645 | $1,164 | $2,590 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.8% expense ratio costs roughly $45,100 in lost growth, versus about $46,700 for the median large blend fund (0.83%).